Searched for
PHARMA RESULTS
Why did market rise today? Sensex jumps 780 points, Nifty ends near 24,000. 6 key factors behind bulls’ return to D-StreetIndian stocks surged on Monday, ending a five-day decline. Easing Iran-US tensions and falling oil prices boosted investor sentiment signif...- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growthLaurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by r...
- US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipelineIndian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy's and Cipla saw signi...
- Nifty in oversold territory; pullback to 24,000 possible: AnalystsThe Nifty 50 has declined and is now near oversold levels. Analysts suggest a potential pullback towards 24,000 if support at 23,600 is mai...
- Bonus issues & dividends: Wipro, UltraTech Cement among more than 110 stocks turning ex-date this week. Do you own?Over 110 companies, including Wipro, UltraTech Cement and Britannia, will turn ex-date this week for dividends and bonus issues. Investors ...
- Will Nifty, Sensex fall for 6th straight session on Monday? US Fed among 5 factors to watch this weekIndian equities extended losses for a fifth session amid rising oil prices, persistent FII outflows and geopolitical tensions. Investors no...
- Cipla Q1 Results: Cons profit drops 39% YoY to Rs 789 crore; revenue rises marginallyCipla Q1 Results: Pharma major Cipla reported a 39% year-on-year decline in Q1FY27 consolidated net profit to Rs 789 crore, mainly due to a...
- Oil at $90-100 will impact macros and the market: Sunil Koul, Goldman SachsGlobal investors show increased interest in India's equity markets recently. Corporate earnings and economic performance have remained quit...
- Why did market fall today? 7 triggers behind Rs 4 lakh crore wealth wipeoutIndian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Two Trades for Today: A mid-cap pharma stock for a 8.69% upmove, a South India-focused private bank for a 7% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- MedPlus Health shares tumble 16% after Q1 profit falls 21% YoY. Should you buy, sell or hold?MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1...
- India engaged with the US, studying all the developments: Govt tells ParliamentThe government told Parliament it is closely monitoring developments in its trade relationship with the US and remains engaged with Washing...
- MSCI India rejig: Eternal likely to see highest inflows at $648 mn; Lenskart, Groww among Nuvama’s expected inclusionsMSCI’s August India Standard Index review could trigger major passive inflows, with Eternal expected to attract the highest at $648 million...
- Stocks in news: CDSL, Adani Energy, L&T, Adani Total Gas, Emcure PharmaMarkets declined on Monday due to disappointing earnings and geopolitical worries. CDSL faced a Rs 1 crore penalty from Sebi for cybersecur...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian markets ended lower as escalating Iran-US tensions and rising crude prices weighed on sentiment. Analysts expect geopolitical risks,...
- Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGATakeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individua...
Load More
